nodes	percent_of_prediction	percent_of_DWPC	metapath
Linezolid—Injury—Rosuvastatin—atherosclerosis	0.00762	0.00777	CcSEcCtD
Linezolid—Drug interaction—Pravastatin—atherosclerosis	0.00746	0.0076	CcSEcCtD
Linezolid—Vaginal inflammation—Niacin—atherosclerosis	0.00703	0.00716	CcSEcCtD
Linezolid—Fluid retention—Niacin—atherosclerosis	0.00667	0.0068	CcSEcCtD
Linezolid—Vaginal infection—Niacin—atherosclerosis	0.00663	0.00676	CcSEcCtD
Linezolid—Neuropathy—Pravastatin—atherosclerosis	0.0065	0.00662	CcSEcCtD
Linezolid—Injury—Lovastatin—atherosclerosis	0.00646	0.00659	CcSEcCtD
Linezolid—Urine output increased—Niacin—atherosclerosis	0.00635	0.00648	CcSEcCtD
Linezolid—Pancreatitis—Rosuvastatin—atherosclerosis	0.00594	0.00605	CcSEcCtD
Linezolid—Polyuria—Niacin—atherosclerosis	0.00581	0.00592	CcSEcCtD
Linezolid—Injury—Pravastatin—atherosclerosis	0.00546	0.00557	CcSEcCtD
Linezolid—Liver function test abnormal—Ezetimibe—atherosclerosis	0.00538	0.00548	CcSEcCtD
Linezolid—Cramp muscle—Lovastatin—atherosclerosis	0.00535	0.00545	CcSEcCtD
Linezolid—Neuropathy peripheral—Rosuvastatin—atherosclerosis	0.00529	0.0054	CcSEcCtD
Linezolid—Cramp muscle—Ezetimibe—atherosclerosis	0.00525	0.00535	CcSEcCtD
Linezolid—Aspartate aminotransferase increased—Ezetimibe—atherosclerosis	0.00525	0.00535	CcSEcCtD
Linezolid—Gastritis—Ezetimibe—atherosclerosis	0.00516	0.00526	CcSEcCtD
Linezolid—Alanine aminotransferase increased—Ezetimibe—atherosclerosis	0.00514	0.00524	CcSEcCtD
Linezolid—Gastrointestinal haemorrhage—Niacin—atherosclerosis	0.0051	0.0052	CcSEcCtD
Linezolid—Eosinophilia—Lovastatin—atherosclerosis	0.00508	0.00518	CcSEcCtD
Linezolid—Pancreatitis—Lovastatin—atherosclerosis	0.00503	0.00513	CcSEcCtD
Linezolid—Cramp muscle—Simvastatin—atherosclerosis	0.005	0.0051	CcSEcCtD
Linezolid—Eosinophilia—Ezetimibe—atherosclerosis	0.00499	0.00508	CcSEcCtD
Linezolid—Pancreatitis—Ezetimibe—atherosclerosis	0.00494	0.00503	CcSEcCtD
Linezolid—Gastritis—Simvastatin—atherosclerosis	0.00492	0.00501	CcSEcCtD
Linezolid—Pharyngitis—Rosuvastatin—atherosclerosis	0.00481	0.0049	CcSEcCtD
Linezolid—Eosinophilia—Simvastatin—atherosclerosis	0.00475	0.00485	CcSEcCtD
Linezolid—Liver function test abnormal—Niacin—atherosclerosis	0.00471	0.0048	CcSEcCtD
Linezolid—Pancreatitis—Simvastatin—atherosclerosis	0.00471	0.0048	CcSEcCtD
Linezolid—Upper respiratory tract infection—Ezetimibe—atherosclerosis	0.00468	0.00477	CcSEcCtD
Linezolid—Liver function test abnormal—Pravastatin—atherosclerosis	0.00464	0.00473	CcSEcCtD
Linezolid—Stevens-Johnson syndrome—Lovastatin—atherosclerosis	0.00454	0.00463	CcSEcCtD
Linezolid—Cramp muscle—Pravastatin—atherosclerosis	0.00452	0.00461	CcSEcCtD
Linezolid—Neuropathy peripheral—Lovastatin—atherosclerosis	0.00449	0.00457	CcSEcCtD
Linezolid—Upper respiratory tract infection—Simvastatin—atherosclerosis	0.00446	0.00455	CcSEcCtD
Linezolid—Alanine aminotransferase increased—Pravastatin—atherosclerosis	0.00443	0.00452	CcSEcCtD
Linezolid—Neuropathy peripheral—Ezetimibe—atherosclerosis	0.0044	0.00449	CcSEcCtD
Linezolid—Eosinophilia—Pravastatin—atherosclerosis	0.0043	0.00438	CcSEcCtD
Linezolid—Pancreatitis—Pravastatin—atherosclerosis	0.00426	0.00434	CcSEcCtD
Linezolid—Stevens-Johnson syndrome—Simvastatin—atherosclerosis	0.00424	0.00433	CcSEcCtD
Linezolid—Sweating increased—Pravastatin—atherosclerosis	0.00423	0.00431	CcSEcCtD
Linezolid—Neuropathy peripheral—Simvastatin—atherosclerosis	0.0042	0.00428	CcSEcCtD
Linezolid—Flatulence—Rosuvastatin—atherosclerosis	0.00416	0.00424	CcSEcCtD
Linezolid—Upper respiratory tract infection—Pravastatin—atherosclerosis	0.00403	0.00411	CcSEcCtD
Linezolid—Pharyngitis—Ezetimibe—atherosclerosis	0.004	0.00408	CcSEcCtD
Linezolid—Erythema multiforme—Lovastatin—atherosclerosis	0.00388	0.00396	CcSEcCtD
Linezolid—Angioedema—Rosuvastatin—atherosclerosis	0.00386	0.00393	CcSEcCtD
Linezolid—Stevens-Johnson syndrome—Pravastatin—atherosclerosis	0.00384	0.00391	CcSEcCtD
Linezolid—Stomatitis—Niacin—atherosclerosis	0.00383	0.00391	CcSEcCtD
Linezolid—Erythema multiforme—Ezetimibe—atherosclerosis	0.00381	0.00388	CcSEcCtD
Linezolid—Neuropathy peripheral—Pravastatin—atherosclerosis	0.00379	0.00387	CcSEcCtD
Linezolid—Chills—Lovastatin—atherosclerosis	0.00369	0.00376	CcSEcCtD
Linezolid—Cough—Rosuvastatin—atherosclerosis	0.00368	0.00375	CcSEcCtD
Linezolid—Erythema multiforme—Simvastatin—atherosclerosis	0.00363	0.0037	CcSEcCtD
Linezolid—Haemoglobin—Niacin—atherosclerosis	0.00355	0.00362	CcSEcCtD
Linezolid—Haemorrhage—Niacin—atherosclerosis	0.00353	0.0036	CcSEcCtD
Linezolid—Flatulence—Lovastatin—atherosclerosis	0.00352	0.00359	CcSEcCtD
Linezolid—Hypoaesthesia—Niacin—atherosclerosis	0.00351	0.00358	CcSEcCtD
Linezolid—Erythema—Ezetimibe—atherosclerosis	0.00351	0.00358	CcSEcCtD
Linezolid—Dysgeusia—Lovastatin—atherosclerosis	0.0035	0.00357	CcSEcCtD
Linezolid—Hypoaesthesia—Pravastatin—atherosclerosis	0.00346	0.00352	CcSEcCtD
Linezolid—Flatulence—Ezetimibe—atherosclerosis	0.00346	0.00352	CcSEcCtD
Linezolid—Pharyngitis—Pravastatin—atherosclerosis	0.00345	0.00352	CcSEcCtD
Linezolid—Chills—Simvastatin—atherosclerosis	0.00345	0.00352	CcSEcCtD
Linezolid—Muscle spasms—Lovastatin—atherosclerosis	0.00344	0.00351	CcSEcCtD
Linezolid—Muscle spasms—Ezetimibe—atherosclerosis	0.00337	0.00344	CcSEcCtD
Linezolid—Thrombocytopenia—Rosuvastatin—atherosclerosis	0.00337	0.00344	CcSEcCtD
Linezolid—Vision blurred—Lovastatin—atherosclerosis	0.00337	0.00344	CcSEcCtD
Linezolid—Erythema—Simvastatin—atherosclerosis	0.00335	0.00341	CcSEcCtD
Linezolid—Flatulence—Simvastatin—atherosclerosis	0.0033	0.00336	CcSEcCtD
Linezolid—Tinnitus—Niacin—atherosclerosis	0.00329	0.00335	CcSEcCtD
Linezolid—Erythema multiforme—Pravastatin—atherosclerosis	0.00329	0.00335	CcSEcCtD
Linezolid—Dysgeusia—Simvastatin—atherosclerosis	0.00328	0.00334	CcSEcCtD
Linezolid—Angioedema—Lovastatin—atherosclerosis	0.00327	0.00333	CcSEcCtD
Linezolid—Anaemia—Ezetimibe—atherosclerosis	0.00324	0.00331	CcSEcCtD
Linezolid—Tinnitus—Pravastatin—atherosclerosis	0.00324	0.0033	CcSEcCtD
Linezolid—Muscle spasms—Simvastatin—atherosclerosis	0.00322	0.00328	CcSEcCtD
Linezolid—Vertigo—Lovastatin—atherosclerosis	0.00321	0.00328	CcSEcCtD
Linezolid—Angioedema—Ezetimibe—atherosclerosis	0.00321	0.00327	CcSEcCtD
Linezolid—Leukopenia—Lovastatin—atherosclerosis	0.0032	0.00326	CcSEcCtD
Linezolid—Chills—Niacin—atherosclerosis	0.00317	0.00323	CcSEcCtD
Linezolid—Vision blurred—Simvastatin—atherosclerosis	0.00315	0.00321	CcSEcCtD
Linezolid—Chills—Pravastatin—atherosclerosis	0.00312	0.00318	CcSEcCtD
Linezolid—Insomnia—Rosuvastatin—atherosclerosis	0.00312	0.00318	CcSEcCtD
Linezolid—Paraesthesia—Rosuvastatin—atherosclerosis	0.00309	0.00315	CcSEcCtD
Linezolid—Anaemia—Simvastatin—atherosclerosis	0.00309	0.00315	CcSEcCtD
Linezolid—Erythema—Niacin—atherosclerosis	0.00307	0.00313	CcSEcCtD
Linezolid—Cough—Ezetimibe—atherosclerosis	0.00306	0.00312	CcSEcCtD
Linezolid—Angioedema—Simvastatin—atherosclerosis	0.00306	0.00312	CcSEcCtD
Linezolid—Dyspepsia—Rosuvastatin—atherosclerosis	0.00303	0.00309	CcSEcCtD
Linezolid—Hypertension—Ezetimibe—atherosclerosis	0.00303	0.00309	CcSEcCtD
Linezolid—Flatulence—Niacin—atherosclerosis	0.00303	0.00309	CcSEcCtD
Linezolid—Vertigo—Simvastatin—atherosclerosis	0.00301	0.00306	CcSEcCtD
Linezolid—Leukopenia—Simvastatin—atherosclerosis	0.00299	0.00305	CcSEcCtD
Linezolid—Flatulence—Pravastatin—atherosclerosis	0.00298	0.00304	CcSEcCtD
Linezolid—Dry mouth—Lovastatin—atherosclerosis	0.00298	0.00304	CcSEcCtD
Linezolid—Dysgeusia—Pravastatin—atherosclerosis	0.00296	0.00302	CcSEcCtD
Linezolid—Muscle spasms—Niacin—atherosclerosis	0.00295	0.00301	CcSEcCtD
Linezolid—Pain—Rosuvastatin—atherosclerosis	0.00295	0.003	CcSEcCtD
Linezolid—Constipation—Rosuvastatin—atherosclerosis	0.00295	0.003	CcSEcCtD
Linezolid—Dry mouth—Ezetimibe—atherosclerosis	0.00292	0.00298	CcSEcCtD
Linezolid—Anaphylactic shock—Lovastatin—atherosclerosis	0.00292	0.00298	CcSEcCtD
Linezolid—Muscle spasms—Pravastatin—atherosclerosis	0.00291	0.00296	CcSEcCtD
Linezolid—Vision blurred—Niacin—atherosclerosis	0.0029	0.00295	CcSEcCtD
Linezolid—Anaphylactic shock—Ezetimibe—atherosclerosis	0.00286	0.00292	CcSEcCtD
Linezolid—Thrombocytopenia—Lovastatin—atherosclerosis	0.00286	0.00291	CcSEcCtD
Linezolid—Vision blurred—Pravastatin—atherosclerosis	0.00285	0.00291	CcSEcCtD
Linezolid—Gastrointestinal pain—Rosuvastatin—atherosclerosis	0.00282	0.00287	CcSEcCtD
Linezolid—Angioedema—Niacin—atherosclerosis	0.00281	0.00286	CcSEcCtD
Linezolid—Thrombocytopenia—Ezetimibe—atherosclerosis	0.0028	0.00286	CcSEcCtD
Linezolid—Anaemia—Pravastatin—atherosclerosis	0.0028	0.00285	CcSEcCtD
Linezolid—Anorexia—Lovastatin—atherosclerosis	0.00278	0.00284	CcSEcCtD
Linezolid—Skin disorder—Ezetimibe—atherosclerosis	0.00278	0.00283	CcSEcCtD
Linezolid—Angioedema—Pravastatin—atherosclerosis	0.00276	0.00282	CcSEcCtD
Linezolid—Vertigo—Niacin—atherosclerosis	0.00276	0.00281	CcSEcCtD
Linezolid—Leukopenia—Niacin—atherosclerosis	0.00275	0.0028	CcSEcCtD
Linezolid—Urticaria—Rosuvastatin—atherosclerosis	0.00274	0.00279	CcSEcCtD
Linezolid—Anaphylactic shock—Simvastatin—atherosclerosis	0.00273	0.00278	CcSEcCtD
Linezolid—Abdominal pain—Rosuvastatin—atherosclerosis	0.00272	0.00278	CcSEcCtD
Linezolid—Vertigo—Pravastatin—atherosclerosis	0.00272	0.00277	CcSEcCtD
Linezolid—Leukopenia—Pravastatin—atherosclerosis	0.00271	0.00276	CcSEcCtD
Linezolid—Cough—Niacin—atherosclerosis	0.00268	0.00273	CcSEcCtD
Linezolid—Thrombocytopenia—Simvastatin—atherosclerosis	0.00267	0.00273	CcSEcCtD
Linezolid—Insomnia—Lovastatin—atherosclerosis	0.00264	0.00269	CcSEcCtD
Linezolid—Cough—Pravastatin—atherosclerosis	0.00264	0.00269	CcSEcCtD
Linezolid—Paraesthesia—Lovastatin—atherosclerosis	0.00262	0.00267	CcSEcCtD
Linezolid—Hypertension—Pravastatin—atherosclerosis	0.00261	0.00266	CcSEcCtD
Linezolid—Anorexia—Simvastatin—atherosclerosis	0.0026	0.00265	CcSEcCtD
Linezolid—Dyspnoea—Lovastatin—atherosclerosis	0.0026	0.00265	CcSEcCtD
Linezolid—Insomnia—Ezetimibe—atherosclerosis	0.00259	0.00264	CcSEcCtD
Linezolid—Paraesthesia—Ezetimibe—atherosclerosis	0.00257	0.00262	CcSEcCtD
Linezolid—Dyspepsia—Lovastatin—atherosclerosis	0.00257	0.00262	CcSEcCtD
Linezolid—Dry mouth—Niacin—atherosclerosis	0.00256	0.00261	CcSEcCtD
Linezolid—Dyspnoea—Ezetimibe—atherosclerosis	0.00255	0.0026	CcSEcCtD
Linezolid—Decreased appetite—Lovastatin—atherosclerosis	0.00254	0.00259	CcSEcCtD
Linezolid—Dyspepsia—Ezetimibe—atherosclerosis	0.00252	0.00257	CcSEcCtD
Linezolid—Fatigue—Lovastatin—atherosclerosis	0.00252	0.00257	CcSEcCtD
Linezolid—Anaphylactic shock—Niacin—atherosclerosis	0.00251	0.00256	CcSEcCtD
Linezolid—Constipation—Lovastatin—atherosclerosis	0.0025	0.00254	CcSEcCtD
Linezolid—Pain—Lovastatin—atherosclerosis	0.0025	0.00254	CcSEcCtD
Linezolid—Decreased appetite—Ezetimibe—atherosclerosis	0.00249	0.00254	CcSEcCtD
Linezolid—Gastrointestinal disorder—Ezetimibe—atherosclerosis	0.00247	0.00252	CcSEcCtD
Linezolid—Asthenia—Rosuvastatin—atherosclerosis	0.00247	0.00252	CcSEcCtD
Linezolid—Insomnia—Simvastatin—atherosclerosis	0.00247	0.00252	CcSEcCtD
Linezolid—Anaphylactic shock—Pravastatin—atherosclerosis	0.00247	0.00252	CcSEcCtD
Linezolid—Fatigue—Ezetimibe—atherosclerosis	0.00247	0.00252	CcSEcCtD
Linezolid—Paraesthesia—Simvastatin—atherosclerosis	0.00245	0.0025	CcSEcCtD
Linezolid—Pain—Ezetimibe—atherosclerosis	0.00245	0.0025	CcSEcCtD
Linezolid—Constipation—Ezetimibe—atherosclerosis	0.00245	0.0025	CcSEcCtD
Linezolid—Pruritus—Rosuvastatin—atherosclerosis	0.00244	0.00248	CcSEcCtD
Linezolid—Skin disorder—Niacin—atherosclerosis	0.00244	0.00248	CcSEcCtD
Linezolid—Dyspnoea—Simvastatin—atherosclerosis	0.00243	0.00248	CcSEcCtD
Linezolid—Hyperhidrosis—Niacin—atherosclerosis	0.00242	0.00247	CcSEcCtD
Linezolid—Thrombocytopenia—Pravastatin—atherosclerosis	0.00242	0.00246	CcSEcCtD
Linezolid—Dyspepsia—Simvastatin—atherosclerosis	0.0024	0.00245	CcSEcCtD
Linezolid—Anorexia—Niacin—atherosclerosis	0.00239	0.00244	CcSEcCtD
Linezolid—Gastrointestinal pain—Lovastatin—atherosclerosis	0.00239	0.00243	CcSEcCtD
Linezolid—Hyperhidrosis—Pravastatin—atherosclerosis	0.00239	0.00243	CcSEcCtD
Linezolid—Decreased appetite—Simvastatin—atherosclerosis	0.00237	0.00242	CcSEcCtD
Linezolid—Gastrointestinal disorder—Simvastatin—atherosclerosis	0.00236	0.0024	CcSEcCtD
Linezolid—Diarrhoea—Rosuvastatin—atherosclerosis	0.00236	0.0024	CcSEcCtD
Linezolid—Fatigue—Simvastatin—atherosclerosis	0.00235	0.0024	CcSEcCtD
Linezolid—Anorexia—Pravastatin—atherosclerosis	0.00235	0.0024	CcSEcCtD
Linezolid—Gastrointestinal pain—Ezetimibe—atherosclerosis	0.00234	0.00239	CcSEcCtD
Linezolid—Pain—Simvastatin—atherosclerosis	0.00233	0.00238	CcSEcCtD
Linezolid—Constipation—Simvastatin—atherosclerosis	0.00233	0.00238	CcSEcCtD
Linezolid—Urticaria—Lovastatin—atherosclerosis	0.00232	0.00236	CcSEcCtD
Linezolid—Body temperature increased—Lovastatin—atherosclerosis	0.00231	0.00235	CcSEcCtD
Linezolid—Abdominal pain—Lovastatin—atherosclerosis	0.00231	0.00235	CcSEcCtD
Linezolid—Dizziness—Rosuvastatin—atherosclerosis	0.00228	0.00232	CcSEcCtD
Linezolid—Urticaria—Ezetimibe—atherosclerosis	0.00227	0.00232	CcSEcCtD
Linezolid—Insomnia—Niacin—atherosclerosis	0.00227	0.00231	CcSEcCtD
Linezolid—Body temperature increased—Ezetimibe—atherosclerosis	0.00226	0.00231	CcSEcCtD
Linezolid—Abdominal pain—Ezetimibe—atherosclerosis	0.00226	0.00231	CcSEcCtD
Linezolid—Paraesthesia—Niacin—atherosclerosis	0.00225	0.00229	CcSEcCtD
Linezolid—Dyspnoea—Niacin—atherosclerosis	0.00224	0.00228	CcSEcCtD
Linezolid—Gastrointestinal pain—Simvastatin—atherosclerosis	0.00223	0.00228	CcSEcCtD
Linezolid—Insomnia—Pravastatin—atherosclerosis	0.00223	0.00228	CcSEcCtD
Linezolid—Somnolence—Niacin—atherosclerosis	0.00223	0.00227	CcSEcCtD
Linezolid—Paraesthesia—Pravastatin—atherosclerosis	0.00222	0.00226	CcSEcCtD
Linezolid—Dyspepsia—Niacin—atherosclerosis	0.00221	0.00225	CcSEcCtD
Linezolid—Dyspnoea—Pravastatin—atherosclerosis	0.0022	0.00224	CcSEcCtD
Linezolid—Decreased appetite—Niacin—atherosclerosis	0.00218	0.00222	CcSEcCtD
Linezolid—Dyspepsia—Pravastatin—atherosclerosis	0.00217	0.00221	CcSEcCtD
Linezolid—Rash—Rosuvastatin—atherosclerosis	0.00217	0.00221	CcSEcCtD
Linezolid—Dermatitis—Rosuvastatin—atherosclerosis	0.00217	0.00221	CcSEcCtD
Linezolid—Urticaria—Simvastatin—atherosclerosis	0.00217	0.00221	CcSEcCtD
Linezolid—Gastrointestinal disorder—Niacin—atherosclerosis	0.00216	0.00221	CcSEcCtD
Linezolid—Abdominal pain—Simvastatin—atherosclerosis	0.00216	0.0022	CcSEcCtD
Linezolid—Body temperature increased—Simvastatin—atherosclerosis	0.00216	0.0022	CcSEcCtD
Linezolid—Headache—Rosuvastatin—atherosclerosis	0.00216	0.0022	CcSEcCtD
Linezolid—Decreased appetite—Pravastatin—atherosclerosis	0.00215	0.00219	CcSEcCtD
Linezolid—Pain—Niacin—atherosclerosis	0.00214	0.00219	CcSEcCtD
Linezolid—Fatigue—Pravastatin—atherosclerosis	0.00213	0.00217	CcSEcCtD
Linezolid—Constipation—Pravastatin—atherosclerosis	0.00211	0.00215	CcSEcCtD
Linezolid—Pain—Pravastatin—atherosclerosis	0.00211	0.00215	CcSEcCtD
Linezolid—Asthenia—Lovastatin—atherosclerosis	0.00209	0.00213	CcSEcCtD
Linezolid—Pruritus—Lovastatin—atherosclerosis	0.00207	0.00211	CcSEcCtD
Linezolid—Asthenia—Ezetimibe—atherosclerosis	0.00205	0.00209	CcSEcCtD
Linezolid—Gastrointestinal pain—Niacin—atherosclerosis	0.00205	0.00209	CcSEcCtD
Linezolid—Nausea—Rosuvastatin—atherosclerosis	0.00205	0.00209	CcSEcCtD
Linezolid—Pruritus—Ezetimibe—atherosclerosis	0.00203	0.00206	CcSEcCtD
Linezolid—Gastrointestinal pain—Pravastatin—atherosclerosis	0.00202	0.00206	CcSEcCtD
Linezolid—Diarrhoea—Lovastatin—atherosclerosis	0.002	0.00204	CcSEcCtD
Linezolid—Urticaria—Niacin—atherosclerosis	0.00199	0.00203	CcSEcCtD
Linezolid—Abdominal pain—Niacin—atherosclerosis	0.00198	0.00202	CcSEcCtD
Linezolid—Body temperature increased—Niacin—atherosclerosis	0.00198	0.00202	CcSEcCtD
Linezolid—Urticaria—Pravastatin—atherosclerosis	0.00196	0.002	CcSEcCtD
Linezolid—Asthenia—Simvastatin—atherosclerosis	0.00196	0.002	CcSEcCtD
Linezolid—Diarrhoea—Ezetimibe—atherosclerosis	0.00196	0.002	CcSEcCtD
Linezolid—Abdominal pain—Pravastatin—atherosclerosis	0.00195	0.00199	CcSEcCtD
Linezolid—Body temperature increased—Pravastatin—atherosclerosis	0.00195	0.00199	CcSEcCtD
Linezolid—Pruritus—Simvastatin—atherosclerosis	0.00193	0.00197	CcSEcCtD
Linezolid—Dizziness—Lovastatin—atherosclerosis	0.00193	0.00197	CcSEcCtD
Linezolid—Dizziness—Ezetimibe—atherosclerosis	0.00189	0.00193	CcSEcCtD
Linezolid—Diarrhoea—Simvastatin—atherosclerosis	0.00187	0.0019	CcSEcCtD
Linezolid—Vomiting—Lovastatin—atherosclerosis	0.00186	0.00189	CcSEcCtD
Linezolid—Rash—Lovastatin—atherosclerosis	0.00184	0.00188	CcSEcCtD
Linezolid—Dermatitis—Lovastatin—atherosclerosis	0.00184	0.00187	CcSEcCtD
Linezolid—Headache—Lovastatin—atherosclerosis	0.00183	0.00186	CcSEcCtD
Linezolid—Vomiting—Ezetimibe—atherosclerosis	0.00182	0.00186	CcSEcCtD
Linezolid—Dizziness—Simvastatin—atherosclerosis	0.00181	0.00184	CcSEcCtD
Linezolid—Rash—Ezetimibe—atherosclerosis	0.00181	0.00184	CcSEcCtD
Linezolid—Dermatitis—Ezetimibe—atherosclerosis	0.0018	0.00184	CcSEcCtD
Linezolid—Asthenia—Niacin—atherosclerosis	0.0018	0.00183	CcSEcCtD
Linezolid—Headache—Ezetimibe—atherosclerosis	0.00179	0.00183	CcSEcCtD
Linezolid—Pruritus—Niacin—atherosclerosis	0.00177	0.00181	CcSEcCtD
Linezolid—Asthenia—Pravastatin—atherosclerosis	0.00177	0.00181	CcSEcCtD
Linezolid—Pruritus—Pravastatin—atherosclerosis	0.00175	0.00178	CcSEcCtD
Linezolid—Vomiting—Simvastatin—atherosclerosis	0.00174	0.00177	CcSEcCtD
Linezolid—Nausea—Lovastatin—atherosclerosis	0.00173	0.00177	CcSEcCtD
Linezolid—MAOA—Oxidative Stress—NOX4—atherosclerosis	0.00173	0.0911	CbGpPWpGaD
Linezolid—Rash—Simvastatin—atherosclerosis	0.00172	0.00175	CcSEcCtD
Linezolid—Dermatitis—Simvastatin—atherosclerosis	0.00172	0.00175	CcSEcCtD
Linezolid—Diarrhoea—Niacin—atherosclerosis	0.00172	0.00175	CcSEcCtD
Linezolid—Headache—Simvastatin—atherosclerosis	0.00171	0.00174	CcSEcCtD
Linezolid—Nausea—Ezetimibe—atherosclerosis	0.0017	0.00173	CcSEcCtD
Linezolid—MAOB—Dopamine metabolism—SOD1—atherosclerosis	0.0017	0.0896	CbGpPWpGaD
Linezolid—Diarrhoea—Pravastatin—atherosclerosis	0.00169	0.00172	CcSEcCtD
Linezolid—Dizziness—Niacin—atherosclerosis	0.00166	0.00169	CcSEcCtD
Linezolid—Dizziness—Pravastatin—atherosclerosis	0.00163	0.00166	CcSEcCtD
Linezolid—Nausea—Simvastatin—atherosclerosis	0.00162	0.00165	CcSEcCtD
Linezolid—Vomiting—Niacin—atherosclerosis	0.00159	0.00162	CcSEcCtD
Linezolid—Rash—Niacin—atherosclerosis	0.00158	0.00161	CcSEcCtD
Linezolid—Dermatitis—Niacin—atherosclerosis	0.00158	0.00161	CcSEcCtD
Linezolid—Headache—Niacin—atherosclerosis	0.00157	0.0016	CcSEcCtD
Linezolid—Vomiting—Pravastatin—atherosclerosis	0.00157	0.0016	CcSEcCtD
Linezolid—Rash—Pravastatin—atherosclerosis	0.00156	0.00159	CcSEcCtD
Linezolid—Dermatitis—Pravastatin—atherosclerosis	0.00156	0.00159	CcSEcCtD
Linezolid—Headache—Pravastatin—atherosclerosis	0.00155	0.00158	CcSEcCtD
Linezolid—Nausea—Niacin—atherosclerosis	0.00149	0.00152	CcSEcCtD
Linezolid—Nausea—Pravastatin—atherosclerosis	0.00147	0.00149	CcSEcCtD
Linezolid—MAOA—Dopamine metabolism—SOD1—atherosclerosis	0.00107	0.0562	CbGpPWpGaD
Linezolid—MAOB—Phase 1 - Functionalization of compounds—CYP7A1—atherosclerosis	0.00088	0.0464	CbGpPWpGaD
Linezolid—MAOB—Phase 1 - Functionalization of compounds—CYP27A1—atherosclerosis	0.000813	0.0429	CbGpPWpGaD
Linezolid—MAOA—Oxidative Stress—CYBA—atherosclerosis	0.000684	0.0361	CbGpPWpGaD
Linezolid—MAOA—Serotonin Transporter Activity—IL1B—atherosclerosis	0.000573	0.0302	CbGpPWpGaD
Linezolid—MAOA—Phase 1 - Functionalization of compounds—CYP7A1—atherosclerosis	0.000552	0.0291	CbGpPWpGaD
Linezolid—MAOA—Oxidative Stress—SOD1—atherosclerosis	0.000546	0.0288	CbGpPWpGaD
Linezolid—MAOA—Oxidative Stress—HMOX1—atherosclerosis	0.000525	0.0277	CbGpPWpGaD
Linezolid—MAOA—Phase 1 - Functionalization of compounds—CYP27A1—atherosclerosis	0.00051	0.0269	CbGpPWpGaD
Linezolid—MAOA—Melatonin metabolism and effects—EDN1—atherosclerosis	0.000509	0.0269	CbGpPWpGaD
Linezolid—MAOA—Oxidative Stress—SOD2—atherosclerosis	0.000491	0.0259	CbGpPWpGaD
Linezolid—MAOA—Oxidative Stress—GPX1—atherosclerosis	0.000469	0.0247	CbGpPWpGaD
Linezolid—MAOB—Biological oxidations—CYP7A1—atherosclerosis	0.000467	0.0247	CbGpPWpGaD
Linezolid—MAOB—Biological oxidations—CYP27A1—atherosclerosis	0.000432	0.0228	CbGpPWpGaD
Linezolid—MAOA—Melatonin metabolism and effects—APOE—atherosclerosis	0.000414	0.0218	CbGpPWpGaD
Linezolid—MAOA—Biological oxidations—CYP7A1—atherosclerosis	0.000293	0.0155	CbGpPWpGaD
Linezolid—MAOA—Biological oxidations—CYP27A1—atherosclerosis	0.000271	0.0143	CbGpPWpGaD
Linezolid—MAOA—SIDS Susceptibility Pathways—HSPD1—atherosclerosis	0.000249	0.0132	CbGpPWpGaD
Linezolid—MAOA—Melatonin metabolism and effects—NFKB1—atherosclerosis	0.000246	0.013	CbGpPWpGaD
Linezolid—MAOA—Oxidative Stress—NFKB1—atherosclerosis	0.00024	0.0126	CbGpPWpGaD
Linezolid—MAOB—Biological oxidations—GSTM1—atherosclerosis	0.000193	0.0102	CbGpPWpGaD
Linezolid—MAOA—SIDS Susceptibility Pathways—ESR2—atherosclerosis	0.00017	0.00895	CbGpPWpGaD
Linezolid—MAOB—Metabolism—LDLRAP1—atherosclerosis	0.000137	0.00722	CbGpPWpGaD
Linezolid—MAOA—SIDS Susceptibility Pathways—IL10—atherosclerosis	0.000131	0.00691	CbGpPWpGaD
Linezolid—MAOB—Metabolism—PLTP—atherosclerosis	0.000129	0.00679	CbGpPWpGaD
Linezolid—MAOA—Biological oxidations—GSTM1—atherosclerosis	0.000121	0.00639	CbGpPWpGaD
Linezolid—MAOB—Metabolism—LTA4H—atherosclerosis	0.000112	0.00589	CbGpPWpGaD
Linezolid—MAOB—Metabolism—ABCG8—atherosclerosis	0.000112	0.00589	CbGpPWpGaD
Linezolid—MAOA—Transmission across Chemical Synapses—PRKCG—atherosclerosis	0.000102	0.0054	CbGpPWpGaD
Linezolid—MAOB—Metabolism—ABCG1—atherosclerosis	8.82e-05	0.00465	CbGpPWpGaD
Linezolid—MAOA—Metabolism—LDLRAP1—atherosclerosis	8.59e-05	0.00453	CbGpPWpGaD
Linezolid—MAOB—Metabolism—LCAT—atherosclerosis	8.29e-05	0.00437	CbGpPWpGaD
Linezolid—MAOB—Metabolism—FABP4—atherosclerosis	8.29e-05	0.00437	CbGpPWpGaD
Linezolid—MAOB—Metabolism—APOA4—atherosclerosis	8.14e-05	0.00429	CbGpPWpGaD
Linezolid—MAOA—Metabolism—PLTP—atherosclerosis	8.07e-05	0.00426	CbGpPWpGaD
Linezolid—MAOB—Metabolism—CYP7A1—atherosclerosis	7.99e-05	0.00422	CbGpPWpGaD
Linezolid—MAOA—Neuronal System—PRKCG—atherosclerosis	7.85e-05	0.00414	CbGpPWpGaD
Linezolid—MAOB—Metabolism—CYP27A1—atherosclerosis	7.39e-05	0.0039	CbGpPWpGaD
Linezolid—MAOA—SIDS Susceptibility Pathways—CXCL8—atherosclerosis	7.16e-05	0.00378	CbGpPWpGaD
Linezolid—MAOB—Metabolism—PLA2G2A—atherosclerosis	7e-05	0.0037	CbGpPWpGaD
Linezolid—MAOB—Metabolism—APOA2—atherosclerosis	7e-05	0.0037	CbGpPWpGaD
Linezolid—MAOB—Metabolism—ALOX5AP—atherosclerosis	7e-05	0.0037	CbGpPWpGaD
Linezolid—MAOB—Metabolism—ALOX15—atherosclerosis	7e-05	0.0037	CbGpPWpGaD
Linezolid—MAOA—Metabolism—ABCG8—atherosclerosis	7e-05	0.00369	CbGpPWpGaD
Linezolid—MAOA—Metabolism—LTA4H—atherosclerosis	7e-05	0.00369	CbGpPWpGaD
Linezolid—MAOB—Metabolism—ABCG5—atherosclerosis	6.92e-05	0.00365	CbGpPWpGaD
Linezolid—MAOA—SIDS Susceptibility Pathways—IL1B—atherosclerosis	6.87e-05	0.00362	CbGpPWpGaD
Linezolid—MAOB—Metabolism—LPA—atherosclerosis	6.68e-05	0.00353	CbGpPWpGaD
Linezolid—MAOB—Metabolism—BGN—atherosclerosis	6.47e-05	0.00341	CbGpPWpGaD
Linezolid—MAOB—Metabolism—APOA5—atherosclerosis	6.41e-05	0.00338	CbGpPWpGaD
Linezolid—MAOA—SIDS Susceptibility Pathways—NFKB1—atherosclerosis	6.41e-05	0.00338	CbGpPWpGaD
Linezolid—MAOB—Metabolism—PLA2G1B—atherosclerosis	6.17e-05	0.00325	CbGpPWpGaD
Linezolid—MAOB—Metabolism—ALOX5—atherosclerosis	5.96e-05	0.00314	CbGpPWpGaD
Linezolid—MAOA—SIDS Susceptibility Pathways—VEGFA—atherosclerosis	5.81e-05	0.00307	CbGpPWpGaD
Linezolid—MAOA—Metabolism—ABCG1—atherosclerosis	5.53e-05	0.00292	CbGpPWpGaD
Linezolid—MAOB—Metabolism—NAMPT—atherosclerosis	5.34e-05	0.00282	CbGpPWpGaD
Linezolid—MAOB—Metabolism—LIPC—atherosclerosis	5.31e-05	0.0028	CbGpPWpGaD
Linezolid—MAOB—Metabolism—APOC3—atherosclerosis	5.28e-05	0.00278	CbGpPWpGaD
Linezolid—MAOB—Metabolism—LDLR—atherosclerosis	5.24e-05	0.00277	CbGpPWpGaD
Linezolid—MAOA—Metabolism—FABP4—atherosclerosis	5.2e-05	0.00274	CbGpPWpGaD
Linezolid—MAOA—Metabolism—LCAT—atherosclerosis	5.2e-05	0.00274	CbGpPWpGaD
Linezolid—MAOB—Metabolism—CETP—atherosclerosis	5.12e-05	0.0027	CbGpPWpGaD
Linezolid—MAOA—Metabolism—APOA4—atherosclerosis	5.11e-05	0.00269	CbGpPWpGaD
Linezolid—MAOA—Metabolism—CYP7A1—atherosclerosis	5.02e-05	0.00265	CbGpPWpGaD
Linezolid—MAOA—SIDS Susceptibility Pathways—TNF—atherosclerosis	4.98e-05	0.00263	CbGpPWpGaD
Linezolid—MAOB—Metabolism—SCARB1—atherosclerosis	4.9e-05	0.00259	CbGpPWpGaD
Linezolid—MAOA—Metabolism—CYP27A1—atherosclerosis	4.64e-05	0.00245	CbGpPWpGaD
Linezolid—MAOB—Metabolism—HMGCR—atherosclerosis	4.63e-05	0.00244	CbGpPWpGaD
Linezolid—MAOA—Metabolism—APOA2—atherosclerosis	4.39e-05	0.00232	CbGpPWpGaD
Linezolid—MAOA—Metabolism—ALOX15—atherosclerosis	4.39e-05	0.00232	CbGpPWpGaD
Linezolid—MAOA—Metabolism—ALOX5AP—atherosclerosis	4.39e-05	0.00232	CbGpPWpGaD
Linezolid—MAOA—Metabolism—PLA2G2A—atherosclerosis	4.39e-05	0.00232	CbGpPWpGaD
Linezolid—MAOA—Metabolism—ABCG5—atherosclerosis	4.34e-05	0.00229	CbGpPWpGaD
Linezolid—MAOA—Metabolism—LPA—atherosclerosis	4.19e-05	0.00221	CbGpPWpGaD
Linezolid—MAOB—Metabolism—ABCA1—atherosclerosis	4.13e-05	0.00218	CbGpPWpGaD
Linezolid—MAOA—Metabolism—BGN—atherosclerosis	4.06e-05	0.00214	CbGpPWpGaD
Linezolid—MAOA—SIDS Susceptibility Pathways—IL6—atherosclerosis	4.02e-05	0.00212	CbGpPWpGaD
Linezolid—MAOA—Metabolism—APOA5—atherosclerosis	4.02e-05	0.00212	CbGpPWpGaD
Linezolid—MAOA—Metabolism—PLA2G1B—atherosclerosis	3.87e-05	0.00204	CbGpPWpGaD
Linezolid—MAOA—Metabolism—ALOX5—atherosclerosis	3.74e-05	0.00197	CbGpPWpGaD
Linezolid—MAOB—Metabolism—HMOX1—atherosclerosis	3.54e-05	0.00187	CbGpPWpGaD
Linezolid—MAOB—Metabolism—APOB—atherosclerosis	3.39e-05	0.00179	CbGpPWpGaD
Linezolid—MAOA—Metabolism—NAMPT—atherosclerosis	3.35e-05	0.00177	CbGpPWpGaD
Linezolid—MAOA—Metabolism—LIPC—atherosclerosis	3.33e-05	0.00176	CbGpPWpGaD
Linezolid—MAOA—Metabolism—APOC3—atherosclerosis	3.31e-05	0.00175	CbGpPWpGaD
Linezolid—MAOB—Metabolism—GSTM1—atherosclerosis	3.3e-05	0.00174	CbGpPWpGaD
Linezolid—MAOA—Metabolism—LDLR—atherosclerosis	3.29e-05	0.00174	CbGpPWpGaD
Linezolid—MAOB—Metabolism—LPL—atherosclerosis	3.24e-05	0.00171	CbGpPWpGaD
Linezolid—MAOA—Metabolism—CETP—atherosclerosis	3.21e-05	0.0017	CbGpPWpGaD
Linezolid—MAOB—Metabolism—GPX1—atherosclerosis	3.16e-05	0.00167	CbGpPWpGaD
Linezolid—MAOB—Metabolism—CD36—atherosclerosis	3.08e-05	0.00162	CbGpPWpGaD
Linezolid—MAOA—Metabolism—SCARB1—atherosclerosis	3.08e-05	0.00162	CbGpPWpGaD
Linezolid—MAOB—Metabolism—MTHFR—atherosclerosis	2.92e-05	0.00154	CbGpPWpGaD
Linezolid—MAOA—Metabolism—HMGCR—atherosclerosis	2.91e-05	0.00153	CbGpPWpGaD
Linezolid—MAOB—Metabolism—PPARA—atherosclerosis	2.86e-05	0.00151	CbGpPWpGaD
Linezolid—MAOB—Metabolism—AGT—atherosclerosis	2.77e-05	0.00146	CbGpPWpGaD
Linezolid—MAOB—Metabolism—APOE—atherosclerosis	2.72e-05	0.00143	CbGpPWpGaD
Linezolid—MAOB—Metabolism—CAV1—atherosclerosis	2.69e-05	0.00142	CbGpPWpGaD
Linezolid—MAOB—Metabolism—APOA1—atherosclerosis	2.68e-05	0.00142	CbGpPWpGaD
Linezolid—MAOA—Metabolism—ABCA1—atherosclerosis	2.59e-05	0.00137	CbGpPWpGaD
Linezolid—MAOB—Metabolism—PIK3CG—atherosclerosis	2.45e-05	0.00129	CbGpPWpGaD
Linezolid—MAOB—Metabolism—PPARG—atherosclerosis	2.36e-05	0.00125	CbGpPWpGaD
Linezolid—MAOB—Metabolism—INS—atherosclerosis	2.32e-05	0.00122	CbGpPWpGaD
Linezolid—MAOA—Metabolism—HMOX1—atherosclerosis	2.22e-05	0.00117	CbGpPWpGaD
Linezolid—MAOA—Metabolism—APOB—atherosclerosis	2.13e-05	0.00112	CbGpPWpGaD
Linezolid—MAOB—Metabolism—ALB—atherosclerosis	2.13e-05	0.00112	CbGpPWpGaD
Linezolid—MAOA—Metabolism—GSTM1—atherosclerosis	2.07e-05	0.00109	CbGpPWpGaD
Linezolid—MAOB—Metabolism—NOS3—atherosclerosis	2.03e-05	0.00107	CbGpPWpGaD
Linezolid—MAOA—Metabolism—LPL—atherosclerosis	2.03e-05	0.00107	CbGpPWpGaD
Linezolid—MAOA—Metabolism—GPX1—atherosclerosis	1.98e-05	0.00105	CbGpPWpGaD
Linezolid—MAOA—Metabolism—CD36—atherosclerosis	1.93e-05	0.00102	CbGpPWpGaD
Linezolid—MAOB—Metabolism—PTGS2—atherosclerosis	1.86e-05	0.000982	CbGpPWpGaD
Linezolid—MAOA—Metabolism—MTHFR—atherosclerosis	1.83e-05	0.000966	CbGpPWpGaD
Linezolid—MAOA—Metabolism—PPARA—atherosclerosis	1.8e-05	0.000947	CbGpPWpGaD
Linezolid—MAOA—Metabolism—AGT—atherosclerosis	1.74e-05	0.000918	CbGpPWpGaD
Linezolid—MAOA—Metabolism—APOE—atherosclerosis	1.7e-05	0.000899	CbGpPWpGaD
Linezolid—MAOA—Metabolism—CAV1—atherosclerosis	1.69e-05	0.000891	CbGpPWpGaD
Linezolid—MAOA—Metabolism—APOA1—atherosclerosis	1.68e-05	0.000889	CbGpPWpGaD
Linezolid—MAOA—Metabolism—PIK3CG—atherosclerosis	1.54e-05	0.000811	CbGpPWpGaD
Linezolid—MAOA—Metabolism—PPARG—atherosclerosis	1.48e-05	0.000783	CbGpPWpGaD
Linezolid—MAOA—Metabolism—INS—atherosclerosis	1.46e-05	0.000768	CbGpPWpGaD
Linezolid—MAOA—Metabolism—ALB—atherosclerosis	1.33e-05	0.000704	CbGpPWpGaD
Linezolid—MAOA—Metabolism—NOS3—atherosclerosis	1.28e-05	0.000674	CbGpPWpGaD
Linezolid—MAOA—Metabolism—PTGS2—atherosclerosis	1.17e-05	0.000616	CbGpPWpGaD
Linezolid—MAOB—Metabolism—AKT1—atherosclerosis	9.35e-06	0.000493	CbGpPWpGaD
Linezolid—MAOA—Metabolism—AKT1—atherosclerosis	5.87e-06	0.00031	CbGpPWpGaD
